
    
      This study was a 8 weeks, randomized, double-blind, placebo-controlled human trial. 80
      subjects were randomly divided into Nokyong Mixture Extract(CME-PI) group or placebo group.
      The investigators measured Natural Killer cell activity, Cytokines(IL-2, IL-12, IFN-γ,
      TNF-α), questionnaire scores of upper airway infection.
    
  